Search results
Results from the WOW.Com Content Network
Topiramate, sold under the brand name Topamax among others, is a medication used to treat epilepsy and prevent migraines. [9] It has also been used for alcohol dependence and essential tremor. [9] For epilepsy, this includes treatment for generalized or focal seizures. [10] It is taken orally (by mouth). [9]
Over time, insomnia can also contribute to chronic health issues like heart disease, high blood pressure, obesity, chronic pain syndrome and diabetes. What are the causes or risk factors for insomnia?
When a person struggles to fall asleep or stay asleep without any obvious cause, it is referred to as insomnia, [2] which is the most common sleep disorder. [3] Other sleep disorders include sleep apnea , narcolepsy , hypersomnia (excessive sleepiness at inappropriate times), sleeping sickness (disruption of the sleep cycle due to infection ...
Used off-label to treat insomnia; Sonata – a non-benzodiazepine hypnotic; Spravato – a rapid-acting antidepressant of the NMDA receptor antagonist class; enantiomer of ketamine; Stelazine (trifluoperazine) – an antipsychotic used in the treatment of psychotic disorders, anxiety, and nausea caused by chemotherapy [2]
Racing thoughts refers to the rapid thought patterns that often occur in manic, hypomanic, or mixed episodes.While racing thoughts are most commonly described in people with bipolar disorder and sleep apnea, they are also common with anxiety disorders, obsessive–compulsive disorder (OCD), and other psychiatric disorders such as attention deficit hyperactivity disorder (ADHD).
Anticonvulsants are also increasingly being used in the treatment of bipolar disorder [2] [3] and borderline personality disorder, [4] since many seem to act as mood stabilizers, and for the treatment of neuropathic pain. [5] Anticonvulsants suppress the excessive rapid firing of neurons during seizures. [6]
Suvorexant is used for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance, in adults. [2] [6] At a dose of 15 to 20 mg and in terms of treatment–placebo difference, it reduces time to sleep onset by up to 10 minutes, reduces time awake after sleep onset by about 15 to 30 minutes, and increases total sleep time by about 10 to 20 minutes. [2]
Idiopathic hypersomnia (IH) is a neurological disorder which is characterized primarily by excessive sleep and excessive daytime sleepiness (EDS). [1] Idiopathic hypersomnia was first described by Bedrich Roth in 1976, and it can be divided into two forms: polysymptomatic and monosymptomatic.